These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35948477)

  • 101. Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution.
    Bartlett NL
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):317-323. PubMed ID: 29222273
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Treatment Strategies in Advanced-Stage Hodgkin Lymphoma.
    Dann EJ; Casasnovas RO
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893177
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Toward a cure for cHL without chemotherapy.
    Lynch RC
    Blood; 2024 Feb; 143(9):741-742. PubMed ID: 38421817
    [No Abstract]   [Full Text] [Related]  

  • 104. Hodgkin lymphoma treatment for older persons in the modern era.
    Evens AM; McKenna M; Ryu Tiger YK; Upshaw JN
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):483-499. PubMed ID: 38066840
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Friedberg JW, Bordoni R, Patel-Donnelly D, et al. Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy. Blood. 2024;143(9):786-795.
    Blood; 2024 Oct; 144(15):1647. PubMed ID: 39388158
    [No Abstract]   [Full Text] [Related]  

  • 106. Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital.
    Boo YL; Ting HSY; Yap DFS; Toh SG; Lim SM
    Blood Res; 2019 Sep; 54(3):210-217. PubMed ID: 31730690
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma.
    Heneghan MB; Parsons SK; Keller FG; Renfro LA; Pei Q; Rodday AM; Wu Y; Punnett A; Belsky JA; Henderson TO; Kelly KM; Castellino SM
    JCO Oncol Pract; 2024 Sep; ():OP2400089. PubMed ID: 39303168
    [TBL] [Abstract][Full Text] [Related]  

  • 108. In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869.
    Casagrande N; Borghese C; Avanzo M; Aldinucci D
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067159
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics.
    Škubník J; Pavlíčková VS; Ruml T; Rimpelová S
    Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571726
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma.
    Yasuda H; Kaga N; Taka H; Ochiai T; Yamana T; Miura Y; Ishii M; Sasaki M; Ando J; Ando M
    Cancer Chemother Pharmacol; 2024 Mar; 93(3):265-268. PubMed ID: 37750932
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
    Wedgwood A; Younes A
    Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S63-6. PubMed ID: 18284718
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
    Yasuda H; Komatsu N; Ando J; Ando M
    Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):805-811. PubMed ID: 35948477
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.
    Yasuda H; Yasuda M; Komatsu N
    Cancer Sci; 2021 Jul; 112(7):2607-2624. PubMed ID: 33938097
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Which Hodgkin's patients in the Unites States should be treated with BEACOPP?
    Cheson BD
    Curr Hematol Malig Rep; 2014 Sep; 9(3):222-6. PubMed ID: 24879421
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
    Gillessen S; Plütschow A; Fuchs M; Markova J; Greil R; Topp MS; Meissner J; Zijlstra JM; Eichenauer DA; Bröckelmann PJ; Diehl V; Borchmann P; Engert A; von Tresckow B
    Lancet Haematol; 2021 Apr; 8(4):e278-e288. PubMed ID: 33770483
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.